Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Scherma

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Biological Psychiatry|August 31, 2010
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptorsPaola Mascia, Marco Pistis, Zuzana Justinova, et al.
British Journal of Pharmacology|April 10, 2021
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlatesNicholas Pintori, Maria Paola Castelli, Cristina Miliano, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in ratsMaria Scherma, Leigh V Panlilio, Paola Fadda, et al.
Brain Sciences|December 23, 2022
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum DisordersMirko Manchia, Ulker Isayeva, Roberto Collu, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 25, 2022
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patientsUlker Isayeva, Mirko Manchia, Roberto Collu, et al.
Cells|September 9, 2022
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate CortexMaria Francesca Palmas, Michela Etzi, Augusta Pisanu, et al.
Schizophrenia Research|February 29, 2024
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort dataUlker Isayeva, Mirko Manchia, Roberto Collu, et al.
Nature Neuroscience|October 15, 2013
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acidZuzana Justinova, Paola Mascia, Hui-Qiu Wu, et al.
International Journal of Molecular Sciences|July 27, 2024
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal StudyPasquale Paribello, Mirko Manchia, Ulker Isayeva, et al.
Frontiers in Psychiatry|November 14, 2024
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disabilityGiacomo Mercuriali, Lorenzo Lodde, Pasquale Paribello, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Biological Psychiatry|August 31, 2010
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptorsPaola Mascia, Marco Pistis, Zuzana Justinova, et al.
British Journal of Pharmacology|April 10, 2021
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlatesNicholas Pintori, Maria Paola Castelli, Cristina Miliano, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in ratsMaria Scherma, Leigh V Panlilio, Paola Fadda, et al.
Brain Sciences|December 23, 2022
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum DisordersMirko Manchia, Ulker Isayeva, Roberto Collu, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 25, 2022
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patientsUlker Isayeva, Mirko Manchia, Roberto Collu, et al.
Cells|September 9, 2022
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate CortexMaria Francesca Palmas, Michela Etzi, Augusta Pisanu, et al.
Schizophrenia Research|February 29, 2024
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort dataUlker Isayeva, Mirko Manchia, Roberto Collu, et al.
Nature Neuroscience|October 15, 2013
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acidZuzana Justinova, Paola Mascia, Hui-Qiu Wu, et al.
International Journal of Molecular Sciences|July 27, 2024
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal StudyPasquale Paribello, Mirko Manchia, Ulker Isayeva, et al.
Frontiers in Psychiatry|November 14, 2024
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disabilityGiacomo Mercuriali, Lorenzo Lodde, Pasquale Paribello, et al.
Pageof 6